These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19125266)

  • 1. The effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome.
    Ozcimen EE; Uckuyu A; Ciftci FC; Zeyneloglu HB
    Arch Gynecol Obstet; 2009 Aug; 280(2):263-9. PubMed ID: 19125266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
    Sahu A; Tripathy P; Mohanty J; Nagy A
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ovarian stromal blood flow after metformin treatment in women with polycystic ovary syndrome.
    Makled AK; El Sherbiny M; Elkabarity R
    Arch Gynecol Obstet; 2014 Apr; 289(4):883-91. PubMed ID: 24196302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study.
    Okyay E; Gode F; Acet F; Bodur T; Cagliyan E; Sahan C; Posaci C; Gulekli B
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():93-9. PubMed ID: 25063905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color Doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome.
    Ozkan S; Vural B; Calişkan E; Bodur H; Türköz E; Vural F
    J Clin Ultrasound; 2007; 35(6):305-13. PubMed ID: 17471581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprasion of ovarian stromal blood flow measured by color Doppler ultrasonography in polycystic ovary syndrome patients and healthy women with ultrasonographic evidence of polycystic.
    Ozdemir O; Sari ME; Kalkan D; Koc EM; Ozdemir S; Atalay CR
    Gynecol Endocrinol; 2015 Apr; 31(4):322-6. PubMed ID: 25558942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
    Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
    Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome.
    Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K
    Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
    Trolle B; Lauszus FF; Frystyk J; Flyvbjerg A
    Fertil Steril; 2010 Nov; 94(6):2234-8. PubMed ID: 20189560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome.
    Adali E; Kolusari A; Adali F; Yildizhan R; Kurdoglu M; Sahin HG
    Int J Gynaecol Obstet; 2009 May; 105(2):154-7. PubMed ID: 19232596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome.
    Hamed HO
    J Obstet Gynaecol Res; 2013 Dec; 39(12):1596-603. PubMed ID: 23875783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome.
    Javanmanesh F; Kashanian M; Rahimi M; Sheikhansari N
    Gynecol Endocrinol; 2016; 32(4):285-9. PubMed ID: 26654154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler parameters of uterine and ovarian stromal blood flow in women with polycystic ovary syndrome and normally ovulating women undergoing controlled ovarian stimulation.
    Pinkas H; Mashiach R; Rabinerson D; Avrech OM; Royburt M; Rufas O; Meizner I; Ben-Rafael Z; Fisch B
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):197-200. PubMed ID: 9793192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
    Kilic S; Yilmaz N; Zulfikaroglu E; Erdogan G; Aydin M; Batioglu S
    Gynecol Endocrinol; 2011 Sep; 27(9):622-9. PubMed ID: 21105835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
    Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
    Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
    Jensterle M; Janez A; Mlinar B; Marc J; Prezelj J; Pfeifer M
    Eur J Endocrinol; 2008 Jun; 158(6):793-801. PubMed ID: 18322300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colour Doppler evaluation of uterine and ovarian blood flow in patients of polycystic ovarian disease and post-treatment changes.
    Dwivedi AND; Ganesh V; Shukla RC; Jain M; Kumar I
    Clin Radiol; 2020 Oct; 75(10):772-779. PubMed ID: 32660710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.